Clinical Trial

Wearable Integration in Symptom Evaluation for Cancer Survivors

Study acronym: WISE
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The objective of this work is the production of actionable insights that can be leveraged to improve remote symptom monitoring (RSM) in varied practice settings, which in turn, is expected to improve timely, efficient, and high-quality comprehensive care in oncology. Aim 1: To assess the feasibility of incorporating a wearable into an RSM program for patients receiving cancer treatment. Aim 2: To assess the relationship between the wearable and ePRO-reported physical symptoms and functional status. Aim 3: To characterize barriers and facilitators of using the wearable in the RSM program and suggest approaches to incorporating relevant evidence-based interventions.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Enrolling by Invitation 2026-04-24
Trial Details
NCT Number NCT07463547
Lead Sponsor University of Alabama at Birmingham
Collaborators: Breast Cancer Research Foundation of Alabama
Conditions Cancer
Enrollment 20 participants
Start Date 2026-04-17
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-23